A rebuttal to “A comment to ‘Normalization of urinary pteridines by urine specific gravity for early cancer detection’ [Clin. Chim. Acta 435 (2014) 42–47]”.

Saved in:
Bibliographic Details
Title: A rebuttal to “A comment to ‘Normalization of urinary pteridines by urine specific gravity for early cancer detection’ [Clin. Chim. Acta 435 (2014) 42–47]”.
Authors: Ma, Yinfa1, Burton, Casey1, Shi, Honglan1
Source: Clinica Chimica Acta. Jan2015, Vol. 438, p415-417. 3p.
Subjects: Pteridines, Breast cancer diagnosis, Urinalysis, Creatinine, Cancer diagnosis
Abstract: We really appreciate the comments from Drs. Reibnegger and Fuchs regarding our recent publication “Normalization of urinary pteridines by urine specific gravity for early cancer detection [Clin. Chim. Acta 435 (2014) 42–47]”. In their letter, Drs. Reibnegger and Fuchs identify several potential concerns regarding our recent publication [1] that evaluated the normalization performance of urine specific gravity (USG) and urinary creatinine with respect to the diagnostic properties of selected pteridines in discerning aggressive and benign breast cancers. Their letter not only provides unique insights that are both relevant and helpful to many researchers engaging in similar studies, but also provides a wonderful opportunity for us to address these potential concerns that may also be shared by other readers. We addressed all of the comments by Drs. Reibnegger and Fuchs in this letter. [ABSTRACT FROM AUTHOR]
Copyright of Clinica Chimica Acta is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Engineering Source
Description
Abstract:We really appreciate the comments from Drs. Reibnegger and Fuchs regarding our recent publication “Normalization of urinary pteridines by urine specific gravity for early cancer detection [Clin. Chim. Acta 435 (2014) 42–47]”. In their letter, Drs. Reibnegger and Fuchs identify several potential concerns regarding our recent publication [1] that evaluated the normalization performance of urine specific gravity (USG) and urinary creatinine with respect to the diagnostic properties of selected pteridines in discerning aggressive and benign breast cancers. Their letter not only provides unique insights that are both relevant and helpful to many researchers engaging in similar studies, but also provides a wonderful opportunity for us to address these potential concerns that may also be shared by other readers. We addressed all of the comments by Drs. Reibnegger and Fuchs in this letter. [ABSTRACT FROM AUTHOR]
ISSN:00098981
DOI:10.1016/j.cca.2014.08.044